Scarica l'app Stockscreener
25.38
0.38%
0.095
Dopo l'orario di chiusura:
25.30
-0.075
-0.30%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Clearpoint Neuro Inc Borsa (CLPT) Ultime notizie
Will ClearPoint Neuro Inc. rebound enough to break evenMarket Sentiment Report & Safe Swing Trade Setups - newser.com
Clearpoint Neuro Stock Forms Golden Cross, Signals Bullish Breakout Ahead - Markets Mojo
Using economic indicators to assess ClearPoint Neuro Inc. potentialJuly 2025 Trends & Low Risk Growth Stock Ideas - newser.com
What momentum indicators show for ClearPoint Neuro Inc. stockMarket Activity Summary & Weekly High Return Stock Forecasts - newser.com
Will ClearPoint Neuro Inc. price bounce be sustainablePortfolio Profit Report & Community Supported Trade Ideas - newser.com
What margin trends mean for ClearPoint Neuro Inc. stockJuly 2025 PreEarnings & Long-Term Investment Growth Plans - newser.com
Can ClearPoint Neuro Inc. stock hit record highs againJuly 2025 Sentiment & Detailed Earnings Play Strategies - newser.com
What the charts say about ClearPoint Neuro Inc. todayVolume Spike & Free Risk Controlled Daily Trade Plans - newser.com
Will earnings trigger a reversal in ClearPoint Neuro Inc.2025 Price Momentum & Verified Swing Trading Watchlists - newser.com
Tools to assess ClearPoint Neuro Inc.’s risk profileDip Buying & Short-Term Trading Alerts - newser.com
Will ClearPoint Neuro Inc. stock beat EPS estimatesJuly 2025 Technicals & Fast Momentum Stock Entry Tips - newser.com
ClearPoint Neuro (CLPT): Assessing Valuation Ahead of Upcoming Industry Conference Reveal - Sahm
ClearPoint Neuro (NASDAQ:CLPT) Sets New 1-Year HighTime to Buy? - MarketBeat
What’s next for ClearPoint Neuro Inc. stock priceEarnings Performance Report & Precise Swing Trade Entry Alerts - newser.com
Combining machine learning predictions for ClearPoint Neuro Inc.July 2025 PostEarnings & Reliable Price Breakout Alerts - newser.com
ClearPoint Neuro's (CLPT) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat
Clearpoint Neuro, Inc. Hits New 52-Week High of $29.85 - Markets Mojo
ClearPoint Neuro Inc. (CLPT) Stock Analysis: Exploring Growth in the Medical Devices Sector - DirectorsTalk Interviews
ClearPoint Neuro (NASDAQ:CLPT) Trading Up 7.4%Should You Buy? - MarketBeat
ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be presented at the CNS Annual Meeting in Los Angeles - MarketScreener
ClearPoint Neuro reports positive results from brain tumor laser therapy study - Investing.com Nigeria
ClearPoint Neuro reports positive results from brain tumor laser therapy study By Investing.com - Investing.com South Africa
ClearPoint Neuro Shares Are Trading Higher Wednesday: What's Going On? - Sahm
ClearPoint Neuro expands regulatory approvals to 34 countries By Investing.com - Investing.com Australia
ClearPoint Neuro expands regulatory approvals to 34 countries - Investing.com
ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide - ACCESS Newswire
34 Countries: ClearPoint Neuro Expands Regulatory Clearances with Canada, Hong Kong and Taiwan additions - Stock Titan
Clearpoint Neuro Reaches New 52-Week High of $28.80, Up 377% - Markets Mojo
CLPT Expands Into Robotic System Supporting Cell and Gene Therapies - The Globe and Mail
Will ClearPoint Neuro Inc. stock benefit from automationJuly 2025 Macro Moves & Reliable Price Breakout Signals - newser.com
Using RSI to spot recovery in ClearPoint Neuro Inc.Trade Volume Report & Real-Time Stock Price Movement Reports - newser.com
Using data models to predict ClearPoint Neuro Inc. stock movementSell Signal & Daily Growth Stock Investment Tips - newser.com
Will ClearPoint Neuro Inc. stock outperform value stocksQuarterly Market Review & Real-Time Stock Price Movement Reports - newser.com
Can ClearPoint Neuro’s (CLPT) New Robotic Platform Redefine Its Clinical Expansion Trajectory? - Sahm
ClearPoint Neuro (NASDAQ:CLPT) Reaches New 12-Month High – Here’s What Happened - Defense World
ClearPoint Neuro (CLPT): Gauging Valuation After Robotic Innovation, Insider Buying, and Huntington’s Therapy Progress - Yahoo Finance
Stifel maintains Clearpoint Neuro stock Buy rating, $17 target - MSN
ClearPoint Neuro (CLPT): Evaluating Valuation After Dr. Paul Larson Announced as Incoming Chief Medical Officer - Sahm
ClearPoint Neuro adds to gains, up 125% since Sept 23 - TradingView
0.73%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):